GO:1904028 positive regulation of collagen fibril organization: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904028 describes any process that increases the frequency, rate, or extent of collagen fibril organization, a biological_process annotation in the Gene Ontology.
• Collagen fibril organization is essential for the structural integrity of the extracellular matrix (ECM) in tissues such as cornea, breast, heart, and blood vessels.
• Positive regulators include TGFB3, ELN, and other ECM-related genes identified through bioinformatics and network analyses in cardiac hypertrophy, breast cancer, and skeletal muscle myogenesis.
• Dysregulated collagen fibril organization contributes to HER2-positive breast cancer brain metastasis, calcific aortic valve disease, and raised mammographic density.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate positive regulators of collagen fibril organization.
• Integrating RNA-seq, proteomics, and imaging with CRISPR screens provides a robust framework to dissect the regulatory network of GO:1904028.
Description
Collagen fibril organization is a fundamental biological process that ensures the proper assembly and spatial arrangement of collagen molecules into fibrils, which are the main structural components of the extracellular matrix (ECM). The Gene Ontology term GO:1904028, positive regulation of collagen fibril organization, captures any process that activates or increases the frequency, rate, or extent of this organization. This term is critical for understanding tissue homeostasis, wound healing, and the pathogenesis of fibrotic and cancer-related disorders. Research into GO:1904028 has been driven by the need to identify molecular players that enhance collagen fibril assembly. For example, in reconstructed corneas, tetracycline hydrochloride and three-dimensional culture conditions modulate newly synthesized ECM, including collagen fibril organization. In breast tissue, increased peri-ductal collagen micro-organization is associated with raised mammographic density, a risk factor for breast cancer. Similarly, in calcific aortic valve disease, localized enrichment of type III collagen and LTBP-4 highlights the importance of positive regulation in disease progression. Bioinformatics and network analyses have revealed key genes such as ELN and TGFB3 that are upregulated in cardiac hypertrophy and associated with severity, suggesting their role as positive regulators of collagen fibril organization. In skeletal muscle myogenesis of livestock animals, network visualization of genes involved in myogenesis has identified collagen-related modules. These findings underscore the importance of GO:1904028 in development, disease, and tissue engineering.
positive regulation of collagen fibril organization At A Glance
| GO ID | GO:1904028 |
|---|---|
| GO term | positive regulation of collagen fibril organization |
| Ontology | biological_process |
| Synonym | activation of collagen fibril organization; upregulation of fibrillar collagen organization; positive regulation of collagen fibril organisation |
| Major function | Enhances the assembly and spatial arrangement of collagen fibrils in the extracellular matrix |
| Related processes | Collagen fibril organization (GO:0030199), extracellular matrix organization (GO:0030198) |
| Disease relevance | Cancer metastasis, calcific aortic valve disease, cardiac hypertrophy, raised mammographic density |
| Research methods | CRISPR knockout/knock-in, RNA-seq, proteomics, imaging, bioinformatics |
What Is GO:1904028?
GO:1904028, positive regulation of collagen fibril organization, is defined as any process that activates or increases the frequency, rate, or extent of collagen fibril organization. This biological_process term encompasses molecular events that promote the assembly, alignment, and stabilization of collagen fibrils, which are essential for ECM structure and function.
Why Is positive regulation of collagen fibril organization Important in Cell Biology?
Understanding positive regulation of collagen fibril organization is crucial because collagen fibrils provide mechanical support to tissues and regulate cell behavior. Dysregulation of this process is linked to a wide range of pathologies, including cancer progression, cardiovascular diseases, and fibrotic disorders. Identifying positive regulators can reveal therapeutic targets and biomarkers for early diagnosis and treatment.
• Collagen fibril organization is essential for tissue integrity and mechanical stability.
• Positive regulation of collagen fibril organization is implicated in cancer metastasis, including HER2-positive breast cancer brain metastasis.
• Altered collagen micro-organization contributes to raised mammographic density, a risk factor for breast cancer.
• Calcific aortic valve disease involves localized enrichment of type III collagen and LTBP-4, indicating positive regulation.
• Cardiac hypertrophy severity is associated with upregulation of ELN and TGFB3, which are positive regulators.
• Skeletal muscle myogenesis in livestock involves coordinated expression of collagen-related genes.
• Colon adenocarcinoma bioinformatics has revealed critical genes in ECM remodeling.
• Collagenome decoding in breast cancer highlights mechanotransduction and microenvironmental cues.
• Reconstructed cornea models show that tetracycline hydrochloride affects newly synthesized ECM.
• CRISPR-based models enable functional validation of positive regulators in disease contexts.
What Happens During positive regulation of collagen fibril organization?
Initiation of Collagen Fibril Assembly
In simple terms: Cells start to produce and assemble collagen molecules into fibrils.
Positive regulation begins with increased synthesis and secretion of collagen precursors, such as type I and III collagens, into the extracellular space. In reconstructed corneas, three-dimensional culture and tetracycline hydrochloride modulate newly synthesized ECM, indicating that environmental cues can enhance collagen fibril organization. In calcific aortic valve disease, type III collagen and LTBP-4 are locally enriched, suggesting active initiation of fibril assembly.
Promotion of Fibril Elongation and Alignment
In simple terms: Fibrils grow longer and line up properly to form strong networks.
Positive regulators enhance the lateral fusion and axial growth of collagen fibrils, leading to mature fibrils with uniform diameter and alignment. In breast tissue, increased peri-ductal collagen micro-organization is associated with raised mammographic density, reflecting enhanced fibril alignment. Bioinformatics analyses in colon adenocarcinoma have identified critical genes that may promote fibril elongation.
Crosslinking and Stabilization
In simple terms: Chemical bonds form between fibrils to make them stable and strong.
Enzymatic crosslinking by lysyl oxidases and transglutaminases stabilizes collagen fibrils. Positive regulation of this step increases tensile strength and resistance to degradation. In cardiac hypertrophy, upregulation of ELN and TGFB3 is associated with severity, potentially through enhanced crosslinking and stabilization of the ECM.
Integration with Cellular Signaling
In simple terms: Cells receive signals from the matrix that influence their behavior.
Collagen fibrils interact with cell surface receptors such as integrins, triggering mechanotransduction pathways that further promote fibril organization. In breast cancer, decoding the collagenome reveals mechanotransduction and microenvironmental feedback loops that amplify positive regulation. Network visualization in skeletal muscle myogenesis highlights coordinated gene modules that integrate signaling with collagen assembly.
Key Genes Involved in GO:1904028 positive regulation of collagen fibril organization
The following genes and proteins have been implicated in positive regulation of collagen fibril organization based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Major fibrillar collagen component | Core structural gene; mutations cause osteogenesis imperfecta; target for ECM studies |
| COL3A1 | Fibrillar collagen in soft tissues | Enriched in calcific aortic valve disease; marker of ECM remodeling |
| TGFB3 | Cytokine promoting collagen synthesis | Upregulated in cardiac hypertrophy; associated with severity |
| ELN | Elastin, interacts with collagen fibrils | Upregulated in cardiac hypertrophy; potential positive regulator |
| LTBP-4 | Latent TGF-beta binding protein | Localized enrichment in calcific aortic valve disease |
| LOX | Lysyl oxidase, crosslinks collagen | Enhances fibril stabilization; target in fibrosis and cancer |
| FN1 | Fibronectin, guides fibril assembly | ECM organizer; involved in mechanotransduction |
| ITGB1 | Integrin beta-1, collagen receptor | Mediates cell-matrix signaling; affects fibril organization |
| MMP2 | Matrix metalloproteinase-2 | Remodels ECM; balance with inhibitors affects fibril organization |
| TIMP1 | Tissue inhibitor of metalloproteinases | Regulates MMP activity; influences collagen accumulation |
| SPARC | Secreted protein acidic and rich in cysteine | Modulates collagen fibril assembly and cell adhesion |
| POSTN | Periostin, matricellular protein | Promotes collagen fibrillogenesis in remodeling tissues |
| FBN1 | Fibrillin-1, microfibril component | Interacts with collagen; mutations cause Marfan syndrome |
| DCN | Decorin, proteoglycan | Regulates collagen fibril diameter and spacing |
| LUM | Lumican, proteoglycan | Influences corneal collagen organization |
| COL5A1 | Minor fibrillar collagen | Regulates fibril nucleation and growth |
| ADAMTS2 | Procollagen N-proteinase | Cleaves propeptides for fibril assembly |
| BGN | Biglycan, proteoglycan | Modulates collagen fibril assembly and signaling |
How Is positive regulation of collagen fibril organization Regulated?
Positive regulation of collagen fibril organization is controlled by a network of signaling pathways, including TGF-beta, integrin-mediated mechanotransduction, and matrix metalloproteinase activity. TGFB3 upregulation in cardiac hypertrophy is associated with increased collagen deposition and severity. In breast cancer, mechanotransduction pathways involving integrins and the collagenome amplify positive regulation. Bioinformatics analyses in colon adenocarcinoma have identified critical genes that may regulate ECM remodeling. Additionally, environmental factors such as tetracycline hydrochloride can modulate newly synthesized ECM in reconstructed corneas.
positive regulation of collagen fibril organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB3 | Cardiac hypertrophy | Knockout or overexpression in cardiomyocytes |
| COL3A1 | Calcific aortic valve disease | Knock-in of mutant COL3A1 in valve interstitial cells |
| ELN | Cardiac hypertrophy | Overexpression in cardiac fibroblasts |
| LTBP-4 | Calcific aortic valve disease | Knockout in aortic valve endothelial cells |
| COL1A1 | Breast cancer metastasis | Knockout in breast cancer cell lines |
Cancer and Metastasis
Positive regulation of collagen fibril organization contributes to tumor progression and metastasis. In HER2-positive breast cancer with brain metastasis, key genes involved in ECM remodeling have been identified via bioinformatics. Increased peri-ductal collagen micro-organization is associated with raised mammographic density, a risk factor for breast cancer. Decoding the collagenome in breast cancer reveals mechanotransduction and microenvironmental cues that promote malignancy. In colon adenocarcinoma, critical genes in ECM remodeling have been uncovered.
Cardiovascular Diseases
In calcific aortic valve disease, localized enrichment of type III collagen and LTBP-4 indicates active positive regulation of collagen fibril organization. Cardiac hypertrophy severity is associated with upregulation of ELN and TGFB3, which may enhance collagen fibril assembly and contribute to pathological remodeling.
Musculoskeletal and Connective Tissue Disorders
Network visualization of genes involved in skeletal muscle myogenesis in livestock animals has highlighted collagen-related modules that are essential for muscle development and repair. In reconstructed corneas, three-dimensional culture and tetracycline hydrochloride affect newly synthesized ECM, including collagen fibril organization, with implications for corneal repair.
From positive regulation of collagen fibril organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate collagen fibril organization? | CRISPR knockout in fibroblasts followed by imaging |
| What is the effect of a point mutation in COL3A1 on fibril assembly? | Point mutation knock-in in cell lines |
| Can overexpression of TGFB3 enhance collagen fibril organization? | Overexpression in cardiac fibroblasts |
| How does LTBP-4 contribute to aortic valve disease? | Knockout in valve interstitial cells |
| What is the role of ELN in cardiac hypertrophy? | Tagged knock-in for live imaging |
| Which genes are essential for collagen fibril organization in breast cancer? | CRISPR library screening in breast cancer cells |
How to Study the positive regulation of collagen fibril organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identifying key genes in cancer and myogenesis |
| Proteomics | Protein abundance and modifications | ECM remodeling in aortic valve disease |
| Second harmonic generation microscopy | Collagen fibril organization | Breast tissue density and cancer risk |
| Electron microscopy | Fibril diameter and alignment | Corneal ECM studies |
| CRISPR knockout screening | Gene function loss | Identifying positive regulators |
| CRISPR activation | Gene overexpression | Enhancing collagen fibril organization |
| Bioinformatics network analysis | Gene-gene interactions | Skeletal muscle myogenesis |
Transcriptomics and Bioinformatics
RNA-seq and bioinformatics analyses have been used to identify key genes in HER2-positive breast cancer brain metastasis, colon adenocarcinoma, and skeletal muscle myogenesis. These methods reveal differentially expressed genes and pathways associated with positive regulation of collagen fibril organization.
Proteomics and ECM Analysis
Proteomic profiling of ECM components, such as in calcific aortic valve disease, has identified localized enrichment of type III collagen and LTBP-4. Mass spectrometry-based approaches quantify collagen crosslinks and fibril-associated proteins.
Imaging and Histology
Second harmonic generation microscopy and electron microscopy visualize collagen fibril organization in tissues. In breast tissue, increased peri-ductal collagen micro-organization is assessed by imaging. Reconstructed corneas are evaluated for newly synthesized ECM using histological methods.
CRISPR Screening and Functional Genomics
CRISPR knockout and activation screens enable systematic identification of positive regulators of collagen fibril organization. In breast cancer, decoding the collagenome highlights mechanotransduction pathways that can be targeted by CRISPR. Network visualization in livestock myogenesis provides candidate genes for functional validation.
How CRISPR Can Be Used to Study GO:1904028 positive regulation of collagen fibril organization
Knockout
CRISPR knockout of candidate genes such as COL1A1 or TGFB3 in cell models can determine whether they are required for positive regulation of collagen fibril organization. For example, knockout of ELN in cardiac fibroblasts may reduce collagen fibril assembly.
Point Mutation
Point mutation knock-in models, such as those introducing disease-associated mutations in COL3A1, can reveal how specific amino acid changes affect collagen fibril organization in calcific aortic valve disease.
Knock-in
Tagged knock-in of genes like LTBP-4 allows live imaging and tracking of protein localization during collagen fibril assembly in valve interstitial cells.
Overexpression
Overexpression of positive regulators such as TGFB3 or ELN in cardiac fibroblasts can enhance collagen fibril organization and mimic hypertrophic remodeling. In breast cancer cells, overexpression of collagenome genes may promote mechanotransduction and metastasis.
How EDITGENE Supports positive regulation of collagen fibril organization Research
Researchers studying positive regulation of collagen fibril organization-related genes often need to determine whether a candidate gene is causally involved in fibril assembly, stabilization, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of collagen fibril organization research.
Frequently Asked Questions About positive regulation of collagen fibril organization
What is GO:1904028?
GO:1904028 is the Gene Ontology term for positive regulation of collagen fibril organization, a biological process that increases the frequency, rate, or extent of collagen fibril assembly.
What genes are involved in positive regulation of collagen fibril organization?
Key genes include COL1A1, COL3A1, TGFB3, ELN, LTBP-4, and LOX, as identified in cancer, cardiac hypertrophy, and aortic valve disease studies.
How is collagen fibril organization regulated?
It is regulated by TGF-beta signaling, integrin-mediated mechanotransduction, and matrix metalloproteinases, with feedback from ECM stiffness.
What diseases are associated with collagen fibril organization?
Diseases include HER2-positive breast cancer brain metastasis, calcific aortic valve disease, cardiac hypertrophy, and raised mammographic density.
What methods are used to study positive regulation of collagen fibril organization?
Methods include RNA-seq, proteomics, second harmonic generation microscopy, CRISPR knockout/activation screens, and bioinformatics network analysis.
What is the role of TGFB3 in collagen fibril organization?
TGFB3 is upregulated in cardiac hypertrophy and associated with severity, likely by promoting collagen synthesis and fibril assembly.
How does LTBP-4 contribute to collagen fibril organization?
LTBP-4 is locally enriched in calcific aortic valve disease and may regulate TGF-beta bioavailability and collagen fibril assembly.
Can CRISPR be used to study collagen fibril organization?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal testing of genes in collagen fibril organization.
What is the clinical relevance of collagen fibril organization?
It affects tissue mechanics, cancer progression, and cardiovascular disease, making it a target for diagnostics and therapeutics.
How can I model positive regulation of collagen fibril organization in vitro?
Use CRISPR-edited fibroblasts or cancer cells, three-dimensional culture, and ECM imaging to assess fibril organization.
Conclusion
GO:1904028, positive regulation of collagen fibril organization, is a critical biological process with broad implications for tissue homeostasis and disease. Research has identified key genes such as TGFB3, ELN, and COL3A1 that enhance collagen fibril assembly in cancer, cardiac hypertrophy, and aortic valve disease. Advanced methods including CRISPR screening, RNA-seq, and imaging continue to unravel the regulatory network. EDITGENE offers comprehensive CRISPR services to functionally validate candidate genes and accelerate discoveries in this field. By integrating knockout, knock-in, overexpression, and bioinformatics approaches, researchers can pinpoint causal regulators and develop targeted interventions for collagen-related disorders.
References
- 1. Yang Z et al.. 2023. Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods.. Transl Cancer Res 12(5):1112-1127 PMID: 37304544
- 2. Builles N et al.. 2007. Reconstructed corneas: effect of three-dimensional culture, epithelium, and tetracycline hydrochloride on newly synthesized extracellular matrix.. Cornea 26(10):1239-48 PMID: 18043183
- 3. Nejad FM et al.. 2024. Network visualization of genes involved in skeletal muscle myogenesis in livestock animals.. BMC Genomics 25(1):294 PMID: 38504177
- 4. McConnell JC et al.. 2016. Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.. Breast Cancer Res 18(1):5 PMID: 26747277
- 5. Kemmochi R et al.. 2026. Extracellular matrix remodeling in calcific aortic valve disease: Localized enrichment of type III collagen and LTBP-4.. Matrix Biol Plus 30:100194 PMID: 42164084
- 6. Vigo-Díaz N et al.. 2026. Decoding the Collagenome in Breast Cancer: Mechanotransduction, Microenvironment, and Translational Opportunities.. Int J Mol Sci 27(15) PMID: 42589449
- 7. Zhang R et al.. 2022. Upregulation of key genes Eln and Tgfb3 were associated with the severity of cardiac hypertrophy.. BMC Genomics 23(1):592 PMID: 35964009
- 8. Xi WD et al.. 2017. Bioinformatics analysis of RNA-seq data revealed critical genes in colon adenocarcinoma.. Eur Rev Med Pharmacol Sci 21(13):3012-3020 PMID: 28742206
